Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07422090Recruiting

Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions

Role: collaborator

NCT05934266Phase 4Active Not Recruiting

Impact of Mesh Fixation With Tissue Adhesive

Role: lead

NCT04906343Not ApplicableCompleted

Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced Neoplasia

Role: lead

NCT06144567Not Yet Recruiting

Response to Upadacitinib of Enthesitis Evaluated by Ultrasound in Patients With Psoriatic Arthritis

Role: collaborator

NCT04697329Phase 4Completed

Local Infiltration With Levobupivacaine During Laparoscopic Cholecystectomy

Role: lead

NCT04379258Completed

Analysis of Mortality of Critically Ill Patients With COVID-19

Role: collaborator

NCT03476434Not ApplicableCompleted

Chromoendoscopy for Serrated Polyposis Syndrome

Role: lead

All 7 trials loaded